- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Acorda Therapeutics Inc
+ Add to WatchlistACOR:US
32.0800 USD 0.3200 0.99%As of 20:10:00 ET on 05/22/2013.
Company Profile for Acorda Therapeutics Inc (ACOR)
Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.
Contact Information
Acorda Therapeutics Inc
420 Saw Mill River Road
Ardsley, NY 10502
United States
Key Executives for Acorda Therapeutics Inc (ACOR)
| Ron CohenPresident/CEO/Founder | David LawrenceChief Financial Officer |
| Enrique J CarrazanaChief Medical Officer | Andrew R Blight "Andy"Chief Scientific Officer |
| Jane WasmanPres:Intl/Secy/Gen Cnsl | Lauren M SabellaExec VP:Commercial Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page